Hong Kong’s IPO Boom

A new listing comes with a deadline. Investors have a limited window to read the prospectus, decide whether the price makes sense and submit an application. When the market is busy, that decision can feel more urgent than it needs to be.

Hong Kong’s IPO fundraising has increased sharply. That creates more opportunities to examine, but it also means more companies competing for investors’ attention and money.

For someone buying shares, the practical question is whether the business can justify the price being asked. A crowded order book, a familiar brand and a prominent institutional investor can all attract attention. None tells you enough about future earnings, cash requirements or the price at which you may eventually sell.

What does Hong Kong’s IPO boom actually measure?

Hong Kong IPOs raised HK$388.0 billion in the first nine months of 2026, compared with HK$188.3 billion in the same period of 2025. That represents an increase of approximately 106%.

The market also recorded 118 newly listed companies during those nine months. That total includes two transfers from GEM to the Main Board, so it should not be described simply as 118 IPOs.

These figures describe fundraising and listing activity. They do not measure the returns earned by investors who subscribed to the offerings.

A market can raise more money because it has more transactions, larger transactions or a combination of both. That does not establish whether the average offer price represents good value.

For an individual investment decision, the useful next step is to move from the market total to the company’s accounts. How does it earn revenue? What keeps customers coming back? How much investment will it need after listing? Those questions remain relevant whether the IPO calendar is crowded or quiet.

Can you explain how the company makes money?

Start with the business, financial information, risk factors and use-of-proceeds sections of the prospectus. The summary is useful for orientation, but the detailed sections explain assumptions and qualifications that can change the investment case.

Try describing the business without using its industry label. Calling a company a technology platform, healthcare provider or consumer brand leaves several questions unanswered.

Who pays it? What do customers receive? How frequently do they buy? What must the company spend to deliver the product or service?

Then check where revenue comes from. Dependence on one customer, distributor, product or market can make growth fragile. A company may report rising sales while becoming more exposed to the loss of a single commercial relationship.

Read the risk factors alongside the operating numbers. If management identifies customer concentration as a risk, look for the revenue contribution of its largest customers and the terms of their contracts.

The aim is to understand what would have to go wrong for the company’s earnings to disappoint, and whether the offer price leaves room for that possibility.

Does reported profit turn into cash?

Revenue and profit deserve a second check against the cash-flow statement.

A company can record a sale before receiving payment. If receivables rise much faster than revenue, investors should ask whether customers are taking longer to pay or whether the business has changed its credit terms.

Inventory can create a similar problem. Producing goods uses cash, even when the goods remain unsold. Rising inventory may support expansion, but it can also leave the company exposed to discounting or write-downs.

Compare operating cash flow with earnings over several periods. Explain large differences before treating either number as a reliable guide to future performance.

Adjusted profit also needs attention. Identify every excluded cost and ask whether it is likely to recur. Removing an expense from a performance measure does not remove its economic effect on shareholders.

For a loss-making issuer, the immediate questions are different: how quickly is cash being spent, what milestones must be reached and how long can available funding support the plan? Revenue growth alone cannot answer them.

Where will the IPO money go?

An offering can contain newly issued shares, existing shares sold by shareholders or both.

Money raised through new shares goes to the company, before deducting the relevant offering expenses. Money paid for existing shares goes to the selling shareholders. A headline transaction value therefore does not necessarily equal the cash available for expansion.

Read the intended uses of the company’s net proceeds. A plan to build a factory, fund research, repay debt or acquire another business involves different execution risks and different timelines.

Debt repayment can improve financial flexibility. It still deserves scrutiny: how much debt remains, when does it mature and what caused the borrowing in the first place?

For an acquisition budget, ask how targets will be selected and whether management has experience integrating similar businesses. For a new facility, examine the construction schedule, expected utilisation and working-capital requirement.

The funding plan should also extend beyond listing day. If the proposed projects require more money than the IPO supplies, shareholders need to understand where the balance might come from.

What do cornerstone investors tell you?

Cornerstone investors receive an assured allocation at the IPO offer price and are normally subject to a six-month lock-up from listing. HKEX retained that six-month requirement in its 2025 reforms.

Their involvement shows that particular investors have committed capital on the disclosed terms. It does not guarantee a successful business, an attractive valuation or a profitable first day of trading.

Read who the investors are and the size of their commitments. Where relevant, examine disclosed commercial relationships with the issuer. An investor with a strategic interest may assess the opportunity differently from someone buying a small portfolio holding.

Also distinguish cornerstone subscriptions from earlier private investments. A shareholder who invested before the IPO may have entered at a different valuation and under different arrangements.

The presence of an established investment firm can help identify questions worth investigating. It cannot tell you whether the shares suit your own time horizon, concentration limits or tolerance for a loss.

How much stock can trade, and who controls the company?

The total number of issued shares differs from the number readily available for trading.

Check the prospectus for public holdings, restrictions on disposals and the amounts held by founders, controlling shareholders and cornerstone investors. Different holdings can have different restrictions and expiry dates.

A relatively small tradeable supply can contribute to sharp price movements. Investors should consider how easily they could sell their intended position if demand weakens.

Lock-up expiry deserves a diary entry, but it should not be treated as a prediction of selling. It changes what a shareholder is permitted to do under the relevant restriction; it does not establish what that shareholder will do.

Ownership also raises governance questions. Who appoints the board? What voting rights attach to the shares being purchased? Are there significant transactions with businesses controlled by the founders?

Finally, review outstanding options, convertible instruments and share incentive arrangements. Future issuance can increase the share count and reduce existing shareholders’ percentage ownership. The valuation should reflect material dilution risks, with the assumptions clearly stated.

Does heavy oversubscription improve the investment case?

Oversubscription measures demand for the shares offered through the relevant subscription pool. It provides no assurance that the shares will trade above their offer price.

Check which pool a reported multiple refers to and how large that pool is. A very high multiple against a small public allocation does not mean the entire company could be sold many times over at the same valuation.

Allocation arrangements also vary. Hong Kong’s framework allows a mechanism with demand-based reallocation to the public tranche and an alternative without that clawback. Read the terms for the particular offering instead of assuming heavy demand will always increase the public allocation.

Borrowing to apply creates another calculation. Financing costs may be based on the amount borrowed, while any investment gain depends on the number of shares actually allotted. Strong demand may leave an applicant with only a small allocation. Interest and fees can absorb a modest gain, and a fall below the offer price adds a trading loss.

Before applying, check the broker’s charges, financing terms and deadline. A large application should follow a deliberate cost calculation.

Is an H-share discount really a bargain?

For a mainland Chinese company with both A shares and H shares, the mainland price can provide a comparison. The comparison needs care.

First, convert the prices into the same currency and use prices from a comparable point in time. Then check the share rights and the basis of the calculation.

A shares and H shares trade in separate markets and are not freely interchangeable. A price gap therefore does not create an automatic route to buy in one market and sell the same shares in the other.

A discount to the A-share price also says little about whether either valuation is reasonable. Both should be tested against the underlying business, its finances and appropriate peers.

Investors whose spending currency differs from the share’s trading currency should consider their own currency exposure. The business may have another exposure again if its revenue, expenses and debt are denominated in different currencies.

Check those risks separately. A favourable movement in the share price can be partly offset by an unfavourable exchange-rate movement when the proceeds are converted home.

What should investors check before applying?

Before committing money, be able to answer these questions:

• Business: What produces revenue, and where is customer or product concentration highest?
• Accounts: Do earnings translate into cash, and which adjustments materially change the profit figure?
• Funding: Who receives the proceeds, how will the company use its share and might it need more capital?
• Valuation: What is the implied value using the full post-IPO share count, and which earnings assumptions support it?
• Ownership: Who controls the votes, what can trade and when do material disposal restrictions expire?
• Application: What allocation terms, fees and financing costs apply?
• Portfolio: How much could you lose without disrupting your other financial commitments?

Write down the reason for buying and the developments that would make you reconsider. That gives subsequent results something concrete to be measured against.

There is also the option to wait. Buying after listing may mean paying more, but it allows you to observe trading and consider later disclosures before committing capital. It offers no guarantee of a better price.

Hong Kong’s fundraising growth gives investors more businesses to investigate. Each still needs to earn its place in a portfolio. If the accounts, offer terms or valuation leave a material question unanswered, the subscription deadline is a poor reason to overlook it.